✦ LIBER ✦

Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate

✍ Scribed by Achim Frese; Florian Bethke; Peter Lüdemann; Florian Stögbauer

Publisher: Springer
Year: 2000
Tongue: English
Weight: 81 KB
Volume: 247
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s004150070118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The development of systemic sclerosis in

The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment

✍ A. Powell; M. L. Myles; E. Yacyshyn 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 78 KB

Development of myasthenia gravis during

Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin

✍ Christine J. Weegink; Robert A. F. M. Chamuleau; Henk W. Reesink; Delmar S. M. M 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 35 KB

Development of leukocytoclastic vasculit

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide

✍ Mathias Witzens; Thomas Moehler; Kai Neben; Stefan Fruehauf; Wolfgang Hartschuh; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 158 KB

State of the cervical section of the spi

State of the cervical section of the spinal cord in patients with remitting multiple sclerosis during immunomodulatory treatment

✍ E. G. Shipova; N. N. Spirin; D. S. Kasatkin; E. I. Shumakov; I. O. Stepanov 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 795 KB

Sclerosis of lytic metastatic bone lesio

Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site

✍ M. Tanaka; H. Fushimi; T. Fuji; J. M. Ford 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 329 KB

European/Canadian multicenter, double-bl

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis

✍ Giancarlo Comi; Massimo Filippi; Jerry S. Wolinsky 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 698 KB

## Abstract Two prior double‐blind, placebo‐controlled, randomized trials demonstrated that glatiramer acetate (GA) reduces relapse rates in patients with relapsing remitting multiple sclerosis (RRMS). This study was designed to determine the effect, onset, and durability of any effect of GA on dis